Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma
Clinical trial NCT05965154 · UNKNOWN
Trial details
- NCT number
- NCT05965154
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2025-04-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.